Condition: Healthy Adult Male and Female Volunteers · Sponsor: Berlin-Chemie AG Menarini Group
The purpose of this study is to evaluate the bioavailability, safety and tolerability of Torasemide 10 mg tablets (Berlin-Chemie AG), compared to Unat® 10 tablets (Viatris Healthcare GmbH) in healthy adult participants under fasting conditions.
This description comes directly from the study's public registry record.
Kai Schumacher, MD · +49 (0)30 6707 · kaischumacher@berlin-chemie.de
Anja Pagenkopf · +49 6707 · apagenkopf@berlin-chemie.de
Always discuss trial participation with your own doctor first.
| LLP MedStartUp | Almaty, Ili District, Otegen Batyr Settlement, Kazakhstan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07201584